Keynote Speaker
Matthias J. Schnell, Ph.D.
Professor and Chair
Department of Microbiology and Immunology
Sidney Kimmel Medical College, Thomas Jefferson University

The research of the Schnell lab focuses on two areas 1) the development of vaccines against emerging viral diseases and 2) viral pathogenicity. With the use of rhabdovirus-based vectors, Dr. Schnell’s group has worked to develop vaccines against emerging diseases such as Ebola virus, MERS-CoV, Zika virus, among others. Due to the recent emergence of SARS-CoV-2, the Schnell lab has begun to turn its focus on the development of a novel SARS-CoV-2 vaccine. In this seminar, Dr. Schnell will discuss his group’s ongoing vaccine development and provide insight into the use of rhabdovirus-based vectors for vaccine development

Student talks – 4:00 – 5:00 pm
Colby Stotesbury, PhD candidate, Thomas Jefferson University
Haley Majer, PhD candidate, Drexel University College of Medicine
Amanda Miller, PhD candidate, Lewis Katz School of Medicine, Temple University

Keynote Speaker – 5:00 – 6:00 pm

This month’s meeting will be held virtually via Zoom. Details for the Zoom meeting will be emailed to the members. If you are not on the email list but would like to participate, please email Vincent Tam, PhD (